Advocacy intelligence hub — real-time data for patient organizations
Groupe Francophone des Myelodysplasies — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Rytelo
Geron Corporation
Rytelo
(IMETELSTAT SODIUM)Orphan drugstandardGeron Corporation
12.1. Mechanism of Action Imetelstat is an oligonucleotide human telomerase inhibitor that binds to the template region of the RNA component of human ...
Browse all Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality news →
Ulrich Germing, Prof.
Heinrich-Heine University, Duesseldorf
Ghulam J Mufti, MB, DM, FRCP, FRCPath
King's College London
Jay Backstrom
Celgene Corporation
Rami Komrokji, M.D
H. Lee Moffitt Cancer Center and Research Institute
📍 TAMPA, FL
Gail Brown
Telik
Eric Feldman
Weill Medical College of Cornell University